2025
SJR Q3
JCR Q3 · 1,5
68 matched articles
SCIE
Journal detail
Acta Cytologica
- Publisher
- S. Karger AG
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
0001554719382650
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,404
- Quartile Q3
- H-Index 70
- Cites/doc 1,19
- Docs (3y) 191
- Cites (3y) 236
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,5
- 5Y JIF 1,8
- JCI 0,57
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Histology Q3
- Medicine (miscellaneous) Q3
- Pathology and Forensic Medicine Q3
Areas
- Medicine
WoS categories
- Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,404 | 1,5 | 1,8 | 0,57 | Q3 | 70 |
| 2024 | Q2 | Q3 | 0,553 | 1,7 | 2,1 | 0,63 | Q3 | 67 |
| 2023 | Q2 | Q3 | 0,565 | 1,6 | 1,9 | 0,52 | Q3 | 67 |
| 2022 | Q2 | Q3 | 0,733 | 1,8 | 2,1 | 0,59 | Q3 | 67 |
| 2021 | Q2 | Q3 | 0,675 | 3 | 2,3 | 0,59 | Q3 | 67 |
| 2020 | Q2 | Q3 | 0,513 | 2,3 | 2,3 | 0,61 | Q3 | 67 |
| 2019 | Q2 | Q4 | 0,533 | 1,2 | — | 0,52 | Q3 | 67 |
| 2017 | Q2 | — | 0,48 | — | — | — | — | 67 |
| 2016 | Q2 | — | 0,483 | — | — | — | — | 67 |
| 2015 | Q2 | — | 0,518 | — | — | — | — | 67 |
| 2014 | Q2 | — | 0,583 | — | — | — | — | 67 |
| 2013 | Q2 | Q3 | 0,526 | 1,6 | 1 | — | — | 67 |
| 2012 | Q3 | Q4 | 0,296 | 0,7 | 0,7 | — | — | 67 |
| 2011 | Q3 | Q4 | 0,344 | 0,5 | 0,6 | — | — | 67 |
| 2010 | Q3 | Q4 | 0,305 | 0,6 | 0,8 | — | — | 67 |
| 2009 | — | Q4 | — | 0,7 | 0,8 | — | — | — |
| 2008 | — | Q4 | — | 0,8 | 0,9 | — | — | — |
| 2007 | — | Q4 | — | 0,7 | 0,9 | — | — | — |
| 2006 | — | Q4 | — | 0,8 | — | — | — | — |
| 2005 | — | Q3 | — | 1 | — | — | — | — |
| 2004 | — | Q4 | — | 0,8 | — | — | — | — |
| 2003 | — | Q3 | — | 1 | — | — | — | — |
| 2002 | — | Q3 | — | 0,9 | — | — | — | — |
| 2001 | — | Q3 | — | 1,1 | — | — | — | — |
| 2000 | — | Q2 | — | 1,4 | — | — | — | — |
| 1999 | — | Q2 | — | 1,3 | — | — | — | — |
| 1998 | — | Q2 | — | 1,2 | — | — | — | — |
| 1997 | — | Q2 | — | 1,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PATHOLOGY | SCIE | Q3 | Q3 | 61/89 |
| 2024 | PATHOLOGY | SCIE | Q3 | Q3 | 52/90 |
| 2023 | PATHOLOGY | SCIE | Q3 | Q3 | 53/88 |
| 2022 | PATHOLOGY | SCIE | Q3 | Q3 | 53/76 |
| 2021 | PATHOLOGY | SCIE | Q3 | Q3 | 43/77 |
| 2020 | PATHOLOGY | SCIE | Q3 | Q3 | 44/77 |
| 2019 | PATHOLOGY | SCIE | Q4 | Q3 | 61/78 |
| 2013 | CELL BIOLOGY | SCIE | Q4 | — | 160/185 |
| 2013 | PATHOLOGY | SCIE | Q3 | — | 54/76 |
| 2012 | CELL BIOLOGY | SCIE | Q4 | — | 173/185 |
| 2012 | PATHOLOGY | SCIE | Q4 | — | 69/77 |
| 2011 | CELL BIOLOGY | SCIE | Q4 | — | 172/181 |
| 2011 | PATHOLOGY | SCIE | Q4 | — | 74/79 |
| 2010 | CELL BIOLOGY | SCIE | Q4 | — | 169/178 |
| 2010 | PATHOLOGY | SCIE | Q4 | — | 66/76 |
| 2009 | CELL BIOLOGY | SCIE | Q4 | — | 156/162 |
| 2009 | PATHOLOGY | SCIE | Q4 | — | 66/71 |
| 2008 | CELL BIOLOGY | SCIE | Q4 | — | 150/157 |
| 2008 | PATHOLOGY | SCIE | Q4 | — | 61/69 |
| 2007 | CELL BIOLOGY | SCIE | Q4 | — | 146/156 |
| 2007 | PATHOLOGY | SCIE | Q4 | — | 59/66 |
| 2006 | CELL BIOLOGY | SCIE | Q4 | — | 144/156 |
| 2006 | PATHOLOGY | SCIE | Q4 | — | 54/64 |
| 2005 | CELL BIOLOGY | SCIE | Q4 | — | 129/153 |
| 2005 | PATHOLOGY | SCIE | Q3 | — | 48/66 |
| 2004 | CELL BIOLOGY | SCIE | Q4 | — | 141/155 |
| 2004 | PATHOLOGY | SCIE | Q4 | — | 51/65 |
| 2003 | CELL BIOLOGY | SCIE | Q4 | — | 128/156 |
| 2003 | PATHOLOGY | SCIE | Q3 | — | 44/64 |
| 2002 | CELL BIOLOGY | SCIE | Q4 | — | 126/153 |
| 2002 | PATHOLOGY | SCIE | Q3 | — | 44/64 |
| 2001 | CELL BIOLOGY | SCIE | Q4 | — | 117/147 |
| 2001 | PATHOLOGY | SCIE | Q3 | — | 35/66 |
| 2000 | CELL BIOLOGY | SCIE | Q3 | — | 97/147 |
| 2000 | PATHOLOGY | SCIE | Q2 | — | 28/67 |
| 1999 | CELL BIOLOGY | SCIE | Q3 | — | 94/141 |
| 1999 | PATHOLOGY | SCIE | Q2 | — | 28/66 |
| 1998 | CELL BIOLOGY | SCIE | Q3 | — | 93/139 |
| 1998 | PATHOLOGY | SCIE | Q2 | — | 25/68 |
| 1997 | CELL BIOLOGY | SCIE | Q3 | — | 79/130 |
| 1997 | PATHOLOGY | SCIE | Q2 | — | 25/66 |